In this section:

29 July 2019

Second Pharmacy Level Recall of Dovobet Gel

If you have an affected product, no new prescription is required, but speak to your doctor if concerned.

A second alert has been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) supporting a precautionary pharmacy level recall for medicines which have been taken out of the regulated medicines’ supply chain during distribution. This follows an earlier alert of the same nature at the beginning of July. Once again, one of the products being recalled is Dovobet Gel, a vitamin d and topical steroid application which is used for the treatment of psoriasis.

MHRA logoThe medicines listed in the alert are believed to be legitimate, but were taken out of the regulated medicines’ supply chain during distribution and later re-introduced. This means that the correct transport and storage conditions cannot be guaranteed during this period and, while unlikely, could impact their effectiveness.

The medicines are stable at room temperature and there is no evidence they were tampered with. This means that the risk of these medicines not being fully effective is greatly reduced or negligible.

As the recall of affected medicines is taking place at pharmacy level, advice from the MHRA is for patients to continue using their Dovobet Gel – there is no need to arrange a new prescription. However, should you have any questions or concerns, please speak to your GP or healthcare professional.

You can find the full press release from the MHRA here, and a full list of the affected batches here.

We use cookies to help us provide you with a better service, but do not track anything that can be used to personally identify you. If you prefer us not to set these cookies, please visit our Cookie Settings page or continue browsing our site to accept them. Close